BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 35954419)

  • 1. The Galaninergic System: A Target for Cancer Treatment.
    Sánchez ML; Coveñas R
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin System in Human Glioma and Pituitary Adenoma.
    Falkenstetter S; Leitner J; Brunner SM; Rieder TN; Kofler B; Weis S
    Front Endocrinol (Lausanne); 2020; 11():155. PubMed ID: 32265844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ala
    Webling K; Runesson J; Lang A; Saar I; Kofler B; Langel Ü
    Neuropeptides; 2016 Dec; 60():75-82. PubMed ID: 27592409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stimulation of GAL1R but not GAL2R attenuates kainic acid-induced neuronal cell death in the rat hippocampus.
    Webling K; Groves-Chapman JL; Runesson J; Saar I; Lang A; Sillard R; Jakovenko E; Kofler B; Holmes PV; Langel Ü
    Neuropeptides; 2016 Aug; 58():83-92. PubMed ID: 26764217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trigeminal nerve injury on the expression of galanin and its receptors in the rat trigeminal ganglion.
    Liu F; Yajima T; Wang M; Shen JF; Ichikawa H; Sato T
    Neuropeptides; 2020 Dec; 84():102098. PubMed ID: 33069139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of pituitary to galanin throughout the reproductive cycle of male European sea bass (Dicentrarchus labrax).
    Pinto P; Velez Z; Sousa C; Santos S; Andrade A; Alvarado MV; Felip A; Zanuy S; Canário AVM
    Gen Comp Endocrinol; 2017 Sep; 250():152-161. PubMed ID: 28636888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galaninergic intramural nerve and tissue reaction to antral ulcerations.
    Zalecki M; Pidsudko Z; Franke-Radowiecka A; Wojtkiewicz J; Kaleczyc J
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13360. PubMed ID: 29717796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.
    Šípková J; Kramáriková I; Hynie S; Klenerová V
    Physiol Res; 2017 Nov; 66(5):729-740. PubMed ID: 28730831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary galaninergic system activity in female rats: the regulatory role of gonadal steroids.
    Gajewska A; Zielinska-Gorska M; Wasilewska-Dziubinska E; Baran M; Kotarba G; Gorski K
    J Physiol Pharmacol; 2016 Jun; 67(3):423-9. PubMed ID: 27512003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat.
    Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The galanin system in cancer.
    Rauch I; Kofler B
    Exp Suppl; 2010; 102():223-41. PubMed ID: 21299072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of galanin receptors in childhood neuroblastic tumors.
    Berger A; Tuechler C; Almer D; Kogner P; Ratschek M; Kerbl R; Iismaa TP; Jones N; Sperl W; Kofler B
    Neuroendocrinology; 2002 Feb; 75(2):130-8. PubMed ID: 11867941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galaninergic signalling and adenylate cyclase.
    Karelson E; Langel U
    Neuropeptides; 1998 Jun; 32(3):197-210. PubMed ID: 10189053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin and its three receptors in human pituitary adenoma.
    Tofighi R; Barde S; Palkovits M; Höög A; Hökfelt T; Ceccatelli S; Hulting AL
    Neuropeptides; 2012 Oct; 46(5):195-201. PubMed ID: 22889491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prof. Arnošt Gutmann 16. 7. 1910 - 6. 8. 1977.
    Vyskočil F
    Physiol Res; 2017 Nov; 66(5):xiii-xvi. PubMed ID: 30993997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of galanin receptor subtypes in RINm5F cells by structurally different galanin radioligands.
    Deecher DC; López FJ
    Peptides; 2002 Mar; 23(3):545-53. PubMed ID: 11836005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.